Phosphorylated tau-217 (pTau-217) is one of the most accurate blood-based biomarkers for Alzheimer’s disease, showing strong correlation with tau pathology and amyloid-associated changes in the brain. It can distinguish Alzheimer’s disease from other neurodegenerative disorders with high sensitivity and specificity.